Why the study?
Does chelation therapy with intravenous injections of edetate disodium improve clinical efficacy and safety in patients with coronary or other arterial atherosclerosis?
Does chelation therapy with intravenous injections of edetate disodium improve clinical efficacy and safety in patients with coronary or other arterial atherosclerosis?
There is currently a lack of acceptable evidence to support the use of chelation therapy for the treatment of atherosclerotic vascular disease.
Answers are grounded in this paper and cite their sources.
Insufficient evidence advises against chelation for atherosclerosis; leaves open whether rigorous RCTs could identify benefit.
Chelation therapy with intravenous injections of edetate disodium is being promoted to the public as a nonsurgical means to treat coronary or other arterial atherosclerosis. The rationale for use, clinical efficacy, and safety are reviewed. Acceptable evidence supporting chelation therapy for atherosclerotic vascular disease is lacking.
No takes yet. Share an insight, caveat, or question.
Rathmann et al. (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: